Puma Biotech (PBYI) Reports Q2 Loss of $1.13

Puma Biotech (NYSE: PBYI) reported Q2 EPS of ($1.13), versus ($1.05) reported last year.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
• StoneX on Mama’s Creations (MAMA): 'We Remain High-Conviction Buyers'